Brief: Neovacs To Present Pre-Clinical Results Of Its Vaccine Candidate IL-4 / IL-13 Kinoid
16/05/2019 06:46
May 16 (Reuters) - NEOVACS SA ALNEV.PA :
* REG-NEOVACS TO PRESENT THE PRE-CLINICAL RESULTS OF ITS
THERAPEUTIC VACCINE CANDIDATE IL-4 / IL-13 KINOID TO TREAT
ALLERGIC ASTHMA
Source text for Eikon: ID:nGNE4cpDNM
Further company coverage: ALNEV.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))
Recent news on Neovacs SA
See all newsBrief: Neovacs And FOCH Hospital Commit To Partnership On Research In Pneumology And Allergology
Brief: Neovacs Presented Latest Results On Its Vaccine Candidates Targeting Allergies
Brief: Neovacs H1 Gross Cash Position Down At EUR 6.2 Mln
Brief: Neovacs: Signature Of Trust Agreement For Equitization Of Bonds Redeemable In Shares With Share Warrants
Brief: Neovacs Launches A Public Offering Of Bonds Redeemable In Shares With Stock Warrants